nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCC1—Dactinomycin—muscle cancer	0.125	0.141	CbGbCtD
Indinavir—ABCC1—Vincristine—muscle cancer	0.077	0.0869	CbGbCtD
Indinavir—ABCC1—Etoposide—muscle cancer	0.0706	0.0796	CbGbCtD
Indinavir—ABCC2—Vincristine—muscle cancer	0.057	0.0643	CbGbCtD
Indinavir—ABCC2—Etoposide—muscle cancer	0.0522	0.0589	CbGbCtD
Indinavir—ABCC1—Doxorubicin—muscle cancer	0.0481	0.0543	CbGbCtD
Indinavir—ABCC1—Methotrexate—muscle cancer	0.0466	0.0526	CbGbCtD
Indinavir—SLCO1A2—Methotrexate—muscle cancer	0.0416	0.047	CbGbCtD
Indinavir—SLCO1B1—Methotrexate—muscle cancer	0.0393	0.0443	CbGbCtD
Indinavir—CYP3A7—Vincristine—muscle cancer	0.0381	0.0429	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0381	0.0429	CbGbCtD
Indinavir—ABCC2—Doxorubicin—muscle cancer	0.0356	0.0402	CbGbCtD
Indinavir—ABCC2—Methotrexate—muscle cancer	0.0345	0.0389	CbGbCtD
Indinavir—ABCB1—Dactinomycin—muscle cancer	0.0302	0.034	CbGbCtD
Indinavir—CYP3A5—Vincristine—muscle cancer	0.0286	0.0322	CbGbCtD
Indinavir—CYP3A5—Etoposide—muscle cancer	0.0262	0.0295	CbGbCtD
Indinavir—ABCB1—Vincristine—muscle cancer	0.0186	0.021	CbGbCtD
Indinavir—ABCB1—Etoposide—muscle cancer	0.017	0.0192	CbGbCtD
Indinavir—ABCB1—Doxorubicin—muscle cancer	0.0116	0.0131	CbGbCtD
Indinavir—ABCB1—Methotrexate—muscle cancer	0.0113	0.0127	CbGbCtD
Indinavir—CYP3A4—Vincristine—muscle cancer	0.0111	0.0126	CbGbCtD
Indinavir—CYP2D6—Doxorubicin—muscle cancer	0.0109	0.0123	CbGbCtD
Indinavir—CYP3A4—Etoposide—muscle cancer	0.0102	0.0115	CbGbCtD
Indinavir—CYP3A4—Doxorubicin—muscle cancer	0.00696	0.00785	CbGbCtD
Indinavir—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000321	0.00282	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000321	0.00282	CcSEcCtD
Indinavir—Alopecia—Etoposide—muscle cancer	0.000317	0.00279	CcSEcCtD
Indinavir—Lymphadenopathy—Doxorubicin—muscle cancer	0.000315	0.00277	CcSEcCtD
Indinavir—Anaphylactic shock—Vincristine—muscle cancer	0.000315	0.00277	CcSEcCtD
Indinavir—Oedema—Vincristine—muscle cancer	0.000315	0.00277	CcSEcCtD
Indinavir—Diabetes mellitus—Doxorubicin—muscle cancer	0.000309	0.00272	CcSEcCtD
Indinavir—Nervous system disorder—Vincristine—muscle cancer	0.000309	0.00271	CcSEcCtD
Indinavir—Thrombocytopenia—Vincristine—muscle cancer	0.000308	0.00271	CcSEcCtD
Indinavir—Decreased appetite—Dactinomycin—muscle cancer	0.000306	0.00269	CcSEcCtD
Indinavir—Dysgeusia—Etoposide—muscle cancer	0.000306	0.00269	CcSEcCtD
Indinavir—Hyperhidrosis—Vincristine—muscle cancer	0.000304	0.00268	CcSEcCtD
Indinavir—Fatigue—Dactinomycin—muscle cancer	0.000304	0.00267	CcSEcCtD
Indinavir—Back pain—Etoposide—muscle cancer	0.000302	0.00266	CcSEcCtD
Indinavir—Pain—Dactinomycin—muscle cancer	0.000301	0.00265	CcSEcCtD
Indinavir—Muscle spasms—Etoposide—muscle cancer	0.0003	0.00264	CcSEcCtD
Indinavir—Anorexia—Vincristine—muscle cancer	0.0003	0.00264	CcSEcCtD
Indinavir—Hepatic failure—Doxorubicin—muscle cancer	0.000299	0.00263	CcSEcCtD
Indinavir—Eye pain—Doxorubicin—muscle cancer	0.000298	0.00262	CcSEcCtD
Indinavir—Renal failure acute—Doxorubicin—muscle cancer	0.000291	0.00256	CcSEcCtD
Indinavir—Feeling abnormal—Dactinomycin—muscle cancer	0.00029	0.00255	CcSEcCtD
Indinavir—Ill-defined disorder—Etoposide—muscle cancer	0.00029	0.00255	CcSEcCtD
Indinavir—Anaemia—Etoposide—muscle cancer	0.000289	0.00254	CcSEcCtD
Indinavir—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000288	0.00253	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000287	0.00252	CcSEcCtD
Indinavir—Increased appetite—Doxorubicin—muscle cancer	0.000286	0.00252	CcSEcCtD
Indinavir—Insomnia—Vincristine—muscle cancer	0.000285	0.0025	CcSEcCtD
Indinavir—Renal impairment—Doxorubicin—muscle cancer	0.000283	0.00249	CcSEcCtD
Indinavir—Paraesthesia—Vincristine—muscle cancer	0.000283	0.00249	CcSEcCtD
Indinavir—Malaise—Etoposide—muscle cancer	0.000282	0.00248	CcSEcCtD
Indinavir—Vertigo—Etoposide—muscle cancer	0.000281	0.00247	CcSEcCtD
Indinavir—Abdominal pain—Dactinomycin—muscle cancer	0.000278	0.00245	CcSEcCtD
Indinavir—Body temperature increased—Dactinomycin—muscle cancer	0.000278	0.00245	CcSEcCtD
Indinavir—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000278	0.00244	CcSEcCtD
Indinavir—Loss of consciousness—Etoposide—muscle cancer	0.000275	0.00241	CcSEcCtD
Indinavir—Decreased appetite—Vincristine—muscle cancer	0.000274	0.00241	CcSEcCtD
Indinavir—Cough—Etoposide—muscle cancer	0.000273	0.0024	CcSEcCtD
Indinavir—Gastrointestinal disorder—Vincristine—muscle cancer	0.000272	0.00239	CcSEcCtD
Indinavir—Fatigue—Vincristine—muscle cancer	0.000271	0.00239	CcSEcCtD
Indinavir—Constipation—Vincristine—muscle cancer	0.000269	0.00237	CcSEcCtD
Indinavir—Pain—Vincristine—muscle cancer	0.000269	0.00237	CcSEcCtD
Indinavir—Pain in extremity—Doxorubicin—muscle cancer	0.000269	0.00237	CcSEcCtD
Indinavir—Chest pain—Etoposide—muscle cancer	0.000266	0.00234	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000264	0.00232	CcSEcCtD
Indinavir—Pancreatitis—Methotrexate—muscle cancer	0.000263	0.00232	CcSEcCtD
Indinavir—Discomfort—Etoposide—muscle cancer	0.000263	0.00231	CcSEcCtD
Indinavir—Hypersensitivity—Dactinomycin—muscle cancer	0.00026	0.00228	CcSEcCtD
Indinavir—Gastrointestinal pain—Vincristine—muscle cancer	0.000257	0.00226	CcSEcCtD
Indinavir—Anaphylactic shock—Etoposide—muscle cancer	0.000255	0.00224	CcSEcCtD
Indinavir—Asthenia—Dactinomycin—muscle cancer	0.000253	0.00222	CcSEcCtD
Indinavir—Blood creatinine increased—Doxorubicin—muscle cancer	0.000252	0.00222	CcSEcCtD
Indinavir—Dysuria—Methotrexate—muscle cancer	0.000251	0.00221	CcSEcCtD
Indinavir—Thrombocytopenia—Etoposide—muscle cancer	0.00025	0.0022	CcSEcCtD
Indinavir—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00025	0.0022	CcSEcCtD
Indinavir—Abdominal pain—Vincristine—muscle cancer	0.000249	0.00219	CcSEcCtD
Indinavir—Body temperature increased—Vincristine—muscle cancer	0.000249	0.00219	CcSEcCtD
Indinavir—Skin disorder—Etoposide—muscle cancer	0.000248	0.00218	CcSEcCtD
Indinavir—Dry skin—Doxorubicin—muscle cancer	0.000247	0.00217	CcSEcCtD
Indinavir—Hyperhidrosis—Etoposide—muscle cancer	0.000246	0.00217	CcSEcCtD
Indinavir—Anorexia—Etoposide—muscle cancer	0.000243	0.00214	CcSEcCtD
Indinavir—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000242	0.00213	CcSEcCtD
Indinavir—Diarrhoea—Dactinomycin—muscle cancer	0.000241	0.00212	CcSEcCtD
Indinavir—Pneumonia—Methotrexate—muscle cancer	0.000241	0.00212	CcSEcCtD
Indinavir—Gastritis—Doxorubicin—muscle cancer	0.000238	0.00209	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000237	0.00209	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000237	0.00209	CcSEcCtD
Indinavir—Muscular weakness—Doxorubicin—muscle cancer	0.000237	0.00209	CcSEcCtD
Indinavir—Renal failure—Methotrexate—muscle cancer	0.000235	0.00207	CcSEcCtD
Indinavir—Abdominal distension—Doxorubicin—muscle cancer	0.000234	0.00206	CcSEcCtD
Indinavir—Hypersensitivity—Vincristine—muscle cancer	0.000232	0.00204	CcSEcCtD
Indinavir—Sweating—Methotrexate—muscle cancer	0.00023	0.00202	CcSEcCtD
Indinavir—Paraesthesia—Etoposide—muscle cancer	0.000229	0.00201	CcSEcCtD
Indinavir—Haematuria—Methotrexate—muscle cancer	0.000228	0.00201	CcSEcCtD
Indinavir—Pancreatitis—Doxorubicin—muscle cancer	0.000228	0.00201	CcSEcCtD
Indinavir—Dyspnoea—Etoposide—muscle cancer	0.000227	0.002	CcSEcCtD
Indinavir—Somnolence—Etoposide—muscle cancer	0.000227	0.00199	CcSEcCtD
Indinavir—Angina pectoris—Doxorubicin—muscle cancer	0.000226	0.00199	CcSEcCtD
Indinavir—Hepatobiliary disease—Methotrexate—muscle cancer	0.000226	0.00199	CcSEcCtD
Indinavir—Asthenia—Vincristine—muscle cancer	0.000226	0.00199	CcSEcCtD
Indinavir—Vomiting—Dactinomycin—muscle cancer	0.000224	0.00197	CcSEcCtD
Indinavir—Rash—Dactinomycin—muscle cancer	0.000222	0.00195	CcSEcCtD
Indinavir—Decreased appetite—Etoposide—muscle cancer	0.000222	0.00195	CcSEcCtD
Indinavir—Gastrointestinal disorder—Etoposide—muscle cancer	0.00022	0.00194	CcSEcCtD
Indinavir—Fatigue—Etoposide—muscle cancer	0.00022	0.00193	CcSEcCtD
Indinavir—Pain—Etoposide—muscle cancer	0.000218	0.00192	CcSEcCtD
Indinavir—Constipation—Etoposide—muscle cancer	0.000218	0.00192	CcSEcCtD
Indinavir—Dysuria—Doxorubicin—muscle cancer	0.000217	0.00191	CcSEcCtD
Indinavir—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000216	0.0019	CcSEcCtD
Indinavir—Haemoglobin—Methotrexate—muscle cancer	0.000216	0.0019	CcSEcCtD
Indinavir—Diarrhoea—Vincristine—muscle cancer	0.000215	0.00189	CcSEcCtD
Indinavir—Haemorrhage—Methotrexate—muscle cancer	0.000215	0.00189	CcSEcCtD
Indinavir—Hepatitis—Methotrexate—muscle cancer	0.000215	0.00189	CcSEcCtD
Indinavir—Pollakiuria—Doxorubicin—muscle cancer	0.000215	0.00189	CcSEcCtD
Indinavir—Pharyngitis—Methotrexate—muscle cancer	0.000213	0.00188	CcSEcCtD
Indinavir—Urinary tract disorder—Methotrexate—muscle cancer	0.000212	0.00187	CcSEcCtD
Indinavir—Weight increased—Doxorubicin—muscle cancer	0.000212	0.00186	CcSEcCtD
Indinavir—Urethral disorder—Methotrexate—muscle cancer	0.000211	0.00185	CcSEcCtD
Indinavir—Feeling abnormal—Etoposide—muscle cancer	0.00021	0.00185	CcSEcCtD
Indinavir—Hyperglycaemia—Doxorubicin—muscle cancer	0.00021	0.00184	CcSEcCtD
Indinavir—Nausea—Dactinomycin—muscle cancer	0.000209	0.00184	CcSEcCtD
Indinavir—Pneumonia—Doxorubicin—muscle cancer	0.000209	0.00183	CcSEcCtD
Indinavir—Gastrointestinal pain—Etoposide—muscle cancer	0.000208	0.00183	CcSEcCtD
Indinavir—Dizziness—Vincristine—muscle cancer	0.000208	0.00183	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000206	0.00181	CcSEcCtD
Indinavir—Renal failure—Doxorubicin—muscle cancer	0.000204	0.00179	CcSEcCtD
Indinavir—Erythema multiforme—Methotrexate—muscle cancer	0.000203	0.00179	CcSEcCtD
Indinavir—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000203	0.00179	CcSEcCtD
Indinavir—Urticaria—Etoposide—muscle cancer	0.000203	0.00178	CcSEcCtD
Indinavir—Jaundice—Doxorubicin—muscle cancer	0.000202	0.00178	CcSEcCtD
Indinavir—Abdominal pain—Etoposide—muscle cancer	0.000202	0.00177	CcSEcCtD
Indinavir—Body temperature increased—Etoposide—muscle cancer	0.000202	0.00177	CcSEcCtD
Indinavir—Urinary tract infection—Doxorubicin—muscle cancer	0.000202	0.00177	CcSEcCtD
Indinavir—Vomiting—Vincristine—muscle cancer	0.0002	0.00176	CcSEcCtD
Indinavir—Sweating—Doxorubicin—muscle cancer	0.000199	0.00175	CcSEcCtD
Indinavir—Rash—Vincristine—muscle cancer	0.000198	0.00175	CcSEcCtD
Indinavir—Dermatitis—Vincristine—muscle cancer	0.000198	0.00174	CcSEcCtD
Indinavir—Haematuria—Doxorubicin—muscle cancer	0.000198	0.00174	CcSEcCtD
Indinavir—Headache—Vincristine—muscle cancer	0.000197	0.00173	CcSEcCtD
Indinavir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000196	0.00172	CcSEcCtD
Indinavir—Sinusitis—Doxorubicin—muscle cancer	0.000194	0.00171	CcSEcCtD
Indinavir—Immune system disorder—Methotrexate—muscle cancer	0.000194	0.00171	CcSEcCtD
Indinavir—Chills—Methotrexate—muscle cancer	0.000193	0.0017	CcSEcCtD
Indinavir—Alopecia—Methotrexate—muscle cancer	0.00019	0.00167	CcSEcCtD
Indinavir—Hypersensitivity—Etoposide—muscle cancer	0.000188	0.00165	CcSEcCtD
Indinavir—Malnutrition—Methotrexate—muscle cancer	0.000187	0.00165	CcSEcCtD
Indinavir—Haemoglobin—Doxorubicin—muscle cancer	0.000187	0.00165	CcSEcCtD
Indinavir—Nausea—Vincristine—muscle cancer	0.000187	0.00164	CcSEcCtD
Indinavir—Hepatitis—Doxorubicin—muscle cancer	0.000186	0.00164	CcSEcCtD
Indinavir—Haemorrhage—Doxorubicin—muscle cancer	0.000186	0.00164	CcSEcCtD
Indinavir—Hypoaesthesia—Doxorubicin—muscle cancer	0.000185	0.00163	CcSEcCtD
Indinavir—Pharyngitis—Doxorubicin—muscle cancer	0.000185	0.00162	CcSEcCtD
Indinavir—Urinary tract disorder—Doxorubicin—muscle cancer	0.000184	0.00162	CcSEcCtD
Indinavir—Dysgeusia—Methotrexate—muscle cancer	0.000183	0.00161	CcSEcCtD
Indinavir—Asthenia—Etoposide—muscle cancer	0.000183	0.00161	CcSEcCtD
Indinavir—Connective tissue disorder—Doxorubicin—muscle cancer	0.000183	0.00161	CcSEcCtD
Indinavir—Urethral disorder—Doxorubicin—muscle cancer	0.000182	0.0016	CcSEcCtD
Indinavir—Back pain—Methotrexate—muscle cancer	0.000181	0.00159	CcSEcCtD
Indinavir—Pruritus—Etoposide—muscle cancer	0.00018	0.00159	CcSEcCtD
Indinavir—Vision blurred—Methotrexate—muscle cancer	0.000176	0.00155	CcSEcCtD
Indinavir—Erythema multiforme—Doxorubicin—muscle cancer	0.000176	0.00155	CcSEcCtD
Indinavir—Diarrhoea—Etoposide—muscle cancer	0.000174	0.00153	CcSEcCtD
Indinavir—Ill-defined disorder—Methotrexate—muscle cancer	0.000174	0.00153	CcSEcCtD
Indinavir—Anaemia—Methotrexate—muscle cancer	0.000173	0.00152	CcSEcCtD
Indinavir—Flushing—Doxorubicin—muscle cancer	0.000173	0.00152	CcSEcCtD
Indinavir—Malaise—Methotrexate—muscle cancer	0.000169	0.00148	CcSEcCtD
Indinavir—Dizziness—Etoposide—muscle cancer	0.000169	0.00148	CcSEcCtD
Indinavir—Immune system disorder—Doxorubicin—muscle cancer	0.000168	0.00148	CcSEcCtD
Indinavir—Vertigo—Methotrexate—muscle cancer	0.000168	0.00148	CcSEcCtD
Indinavir—Chills—Doxorubicin—muscle cancer	0.000167	0.00147	CcSEcCtD
Indinavir—Alopecia—Doxorubicin—muscle cancer	0.000164	0.00145	CcSEcCtD
Indinavir—Cough—Methotrexate—muscle cancer	0.000163	0.00144	CcSEcCtD
Indinavir—Vomiting—Etoposide—muscle cancer	0.000162	0.00143	CcSEcCtD
Indinavir—Malnutrition—Doxorubicin—muscle cancer	0.000162	0.00142	CcSEcCtD
Indinavir—Rash—Etoposide—muscle cancer	0.000161	0.00141	CcSEcCtD
Indinavir—Dermatitis—Etoposide—muscle cancer	0.000161	0.00141	CcSEcCtD
Indinavir—Headache—Etoposide—muscle cancer	0.00016	0.0014	CcSEcCtD
Indinavir—Flatulence—Doxorubicin—muscle cancer	0.00016	0.0014	CcSEcCtD
Indinavir—Myalgia—Methotrexate—muscle cancer	0.000159	0.0014	CcSEcCtD
Indinavir—Chest pain—Methotrexate—muscle cancer	0.000159	0.0014	CcSEcCtD
Indinavir—Arthralgia—Methotrexate—muscle cancer	0.000159	0.0014	CcSEcCtD
Indinavir—Tension—Doxorubicin—muscle cancer	0.000159	0.0014	CcSEcCtD
Indinavir—Dysgeusia—Doxorubicin—muscle cancer	0.000159	0.0014	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000158	0.00139	CcSEcCtD
Indinavir—Discomfort—Methotrexate—muscle cancer	0.000157	0.00138	CcSEcCtD
Indinavir—Nervousness—Doxorubicin—muscle cancer	0.000157	0.00138	CcSEcCtD
Indinavir—Back pain—Doxorubicin—muscle cancer	0.000157	0.00138	CcSEcCtD
Indinavir—Muscle spasms—Doxorubicin—muscle cancer	0.000156	0.00137	CcSEcCtD
Indinavir—Anaphylactic shock—Methotrexate—muscle cancer	0.000153	0.00134	CcSEcCtD
Indinavir—Vision blurred—Doxorubicin—muscle cancer	0.000153	0.00134	CcSEcCtD
Indinavir—Nausea—Etoposide—muscle cancer	0.000151	0.00133	CcSEcCtD
Indinavir—Ill-defined disorder—Doxorubicin—muscle cancer	0.00015	0.00132	CcSEcCtD
Indinavir—Nervous system disorder—Methotrexate—muscle cancer	0.00015	0.00132	CcSEcCtD
Indinavir—Anaemia—Doxorubicin—muscle cancer	0.00015	0.00132	CcSEcCtD
Indinavir—Thrombocytopenia—Methotrexate—muscle cancer	0.00015	0.00131	CcSEcCtD
Indinavir—Agitation—Doxorubicin—muscle cancer	0.000149	0.00131	CcSEcCtD
Indinavir—Skin disorder—Methotrexate—muscle cancer	0.000148	0.0013	CcSEcCtD
Indinavir—Hyperhidrosis—Methotrexate—muscle cancer	0.000148	0.0013	CcSEcCtD
Indinavir—Malaise—Doxorubicin—muscle cancer	0.000146	0.00129	CcSEcCtD
Indinavir—Vertigo—Doxorubicin—muscle cancer	0.000146	0.00128	CcSEcCtD
Indinavir—Anorexia—Methotrexate—muscle cancer	0.000146	0.00128	CcSEcCtD
Indinavir—Syncope—Doxorubicin—muscle cancer	0.000145	0.00128	CcSEcCtD
Indinavir—Palpitations—Doxorubicin—muscle cancer	0.000143	0.00126	CcSEcCtD
Indinavir—Loss of consciousness—Doxorubicin—muscle cancer	0.000142	0.00125	CcSEcCtD
Indinavir—Cough—Doxorubicin—muscle cancer	0.000141	0.00124	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000139	0.00122	CcSEcCtD
Indinavir—Insomnia—Methotrexate—muscle cancer	0.000138	0.00121	CcSEcCtD
Indinavir—Myalgia—Doxorubicin—muscle cancer	0.000138	0.00121	CcSEcCtD
Indinavir—Arthralgia—Doxorubicin—muscle cancer	0.000138	0.00121	CcSEcCtD
Indinavir—Chest pain—Doxorubicin—muscle cancer	0.000138	0.00121	CcSEcCtD
Indinavir—Anxiety—Doxorubicin—muscle cancer	0.000137	0.00121	CcSEcCtD
Indinavir—Paraesthesia—Methotrexate—muscle cancer	0.000137	0.00121	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000137	0.0012	CcSEcCtD
Indinavir—Discomfort—Doxorubicin—muscle cancer	0.000136	0.0012	CcSEcCtD
Indinavir—Dyspnoea—Methotrexate—muscle cancer	0.000136	0.0012	CcSEcCtD
Indinavir—Somnolence—Methotrexate—muscle cancer	0.000136	0.00119	CcSEcCtD
Indinavir—Dry mouth—Doxorubicin—muscle cancer	0.000135	0.00119	CcSEcCtD
Indinavir—Dyspepsia—Methotrexate—muscle cancer	0.000134	0.00118	CcSEcCtD
Indinavir—Decreased appetite—Methotrexate—muscle cancer	0.000133	0.00117	CcSEcCtD
Indinavir—Oedema—Doxorubicin—muscle cancer	0.000132	0.00116	CcSEcCtD
Indinavir—Anaphylactic shock—Doxorubicin—muscle cancer	0.000132	0.00116	CcSEcCtD
Indinavir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000132	0.00116	CcSEcCtD
Indinavir—Fatigue—Methotrexate—muscle cancer	0.000132	0.00116	CcSEcCtD
Indinavir—Pain—Methotrexate—muscle cancer	0.000131	0.00115	CcSEcCtD
Indinavir—Shock—Doxorubicin—muscle cancer	0.00013	0.00114	CcSEcCtD
Indinavir—Nervous system disorder—Doxorubicin—muscle cancer	0.00013	0.00114	CcSEcCtD
Indinavir—Thrombocytopenia—Doxorubicin—muscle cancer	0.000129	0.00114	CcSEcCtD
Indinavir—Skin disorder—Doxorubicin—muscle cancer	0.000128	0.00113	CcSEcCtD
Indinavir—Hyperhidrosis—Doxorubicin—muscle cancer	0.000128	0.00112	CcSEcCtD
Indinavir—Anorexia—Doxorubicin—muscle cancer	0.000126	0.00111	CcSEcCtD
Indinavir—Feeling abnormal—Methotrexate—muscle cancer	0.000126	0.00111	CcSEcCtD
Indinavir—Gastrointestinal pain—Methotrexate—muscle cancer	0.000125	0.0011	CcSEcCtD
Indinavir—Urticaria—Methotrexate—muscle cancer	0.000121	0.00107	CcSEcCtD
Indinavir—Body temperature increased—Methotrexate—muscle cancer	0.000121	0.00106	CcSEcCtD
Indinavir—Abdominal pain—Methotrexate—muscle cancer	0.000121	0.00106	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00012	0.00106	CcSEcCtD
Indinavir—Insomnia—Doxorubicin—muscle cancer	0.00012	0.00105	CcSEcCtD
Indinavir—Paraesthesia—Doxorubicin—muscle cancer	0.000119	0.00104	CcSEcCtD
Indinavir—Dyspnoea—Doxorubicin—muscle cancer	0.000118	0.00104	CcSEcCtD
Indinavir—Somnolence—Doxorubicin—muscle cancer	0.000118	0.00103	CcSEcCtD
Indinavir—Dyspepsia—Doxorubicin—muscle cancer	0.000116	0.00102	CcSEcCtD
Indinavir—Decreased appetite—Doxorubicin—muscle cancer	0.000115	0.00101	CcSEcCtD
Indinavir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000114	0.001	CcSEcCtD
Indinavir—Fatigue—Doxorubicin—muscle cancer	0.000114	0.001	CcSEcCtD
Indinavir—Constipation—Doxorubicin—muscle cancer	0.000113	0.000995	CcSEcCtD
Indinavir—Pain—Doxorubicin—muscle cancer	0.000113	0.000995	CcSEcCtD
Indinavir—Hypersensitivity—Methotrexate—muscle cancer	0.000112	0.00099	CcSEcCtD
Indinavir—Asthenia—Methotrexate—muscle cancer	0.00011	0.000964	CcSEcCtD
Indinavir—Feeling abnormal—Doxorubicin—muscle cancer	0.000109	0.000958	CcSEcCtD
Indinavir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000108	0.000951	CcSEcCtD
Indinavir—Pruritus—Methotrexate—muscle cancer	0.000108	0.00095	CcSEcCtD
Indinavir—Urticaria—Doxorubicin—muscle cancer	0.000105	0.000924	CcSEcCtD
Indinavir—Abdominal pain—Doxorubicin—muscle cancer	0.000105	0.000919	CcSEcCtD
Indinavir—Body temperature increased—Doxorubicin—muscle cancer	0.000105	0.000919	CcSEcCtD
Indinavir—Diarrhoea—Methotrexate—muscle cancer	0.000104	0.000919	CcSEcCtD
Indinavir—Dizziness—Methotrexate—muscle cancer	0.000101	0.000888	CcSEcCtD
Indinavir—Hypersensitivity—Doxorubicin—muscle cancer	9.74e-05	0.000857	CcSEcCtD
Indinavir—Vomiting—Methotrexate—muscle cancer	9.71e-05	0.000854	CcSEcCtD
Indinavir—Rash—Methotrexate—muscle cancer	9.63e-05	0.000847	CcSEcCtD
Indinavir—Dermatitis—Methotrexate—muscle cancer	9.62e-05	0.000846	CcSEcCtD
Indinavir—Headache—Methotrexate—muscle cancer	9.57e-05	0.000841	CcSEcCtD
Indinavir—Asthenia—Doxorubicin—muscle cancer	9.49e-05	0.000834	CcSEcCtD
Indinavir—Pruritus—Doxorubicin—muscle cancer	9.35e-05	0.000823	CcSEcCtD
Indinavir—Nausea—Methotrexate—muscle cancer	9.07e-05	0.000798	CcSEcCtD
Indinavir—Diarrhoea—Doxorubicin—muscle cancer	9.05e-05	0.000796	CcSEcCtD
Indinavir—Dizziness—Doxorubicin—muscle cancer	8.74e-05	0.000769	CcSEcCtD
Indinavir—Vomiting—Doxorubicin—muscle cancer	8.41e-05	0.000739	CcSEcCtD
Indinavir—Rash—Doxorubicin—muscle cancer	8.34e-05	0.000733	CcSEcCtD
Indinavir—Dermatitis—Doxorubicin—muscle cancer	8.33e-05	0.000733	CcSEcCtD
Indinavir—Headache—Doxorubicin—muscle cancer	8.28e-05	0.000729	CcSEcCtD
Indinavir—Nausea—Doxorubicin—muscle cancer	7.85e-05	0.000691	CcSEcCtD
